Diabetes education - Prescribing update for South Yorkshire
For all prescribers for diabetes in Primary care:
Type 2 diabetes update focusing on tirzepatide (Mounjaro) injectable and its role in management of Type 2 diabetes in Primary care.
Join Dr Jackie Elliot (Consultant Endocrinologist, Sheffield Teaching Hospital, Foundation Trust) and Charlotte McMurray (Programme Director, Medicines Optimisation (pharmacy integration and development) who will provide a joint prescribing update on Tirzepatide (Mounjaro) injectable ( long-acting GIP (glucose-dependent insulinotropic polypeptide) receptor and GLP-1 (glucagon-like peptide-1) receptor agonist) to enable clinicians in primary care feel confident and competent to prescribe tirzepatide in line with the NICE Technology Appraisal (TA) guidance. We will also consider the greener prescribing agenda
This event is sponsored by Lilly, but all prescribing and treatment advice sits within the South Yorkshire traffic light system and placed based formularies.
